These findings suggest epigenetic silencing of TGF-β signaling in molecular pathogenesis of ALL and possibly p15INK4B and p21CIP1 are inactivated by this mechanism. The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.